The Biology of Cancer Stem Cells and Its Clinical Implication in Hepatocellular Carcinoma

키워드

참고문헌 (86)

1. Dalerba P, "Cancer stem cells and tumor metastasis: first steps into uncharted territory", Cell Stem Cell, 1, pp.241~242 (2007)
2. Fidler IJ, "Biological diversity in metastatic neoplasms: origins and implications", Science, 217, pp.998~1003 (1982)
3. Griffin JD, "Clonogenic cells in acute myeloblastic leukemia", Blood, 68, pp.1185~1195 (1986)
4. Hanahan D, "The hallmarks of cancer", Cell, 100, pp.57~70 (2000)
5. Sabbath KD, "Heterogeneity of clonogenic cells in acute myeloblastic leukemia", J Clin Invest, 75, pp.746~753 (1985)
6. Park CH, "Mouse myeloma tumor stem cells: a primary cell culture assay", J Natl Cancer Inst, 46, pp.411~422 (1971)
7. Clarke MF, "Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells", Cancer Res, 66, pp.9339~9344 (2006)
8. Reya T, "Stem cells, cancer, and cancer stem cells", Nature, 414, pp.105~111 (2001)
9. Bonnet D, "Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell", Nat Med, 3, pp.730~737 (1997)
10. Dick JE, "Stem cells: self-renewal writ in blood", Nature, 423, pp.231~233 (2003)
11. Al-Hajj M, "Prospective identification of tumorigenic breast cancer cells", Proc Natl Acad Sci U S A, 100, pp.3983~3988 (2003)
12. Singh SK, "Identification of human brain tumour initiating cells", Nature, 432, pp.396~401 (2004)
13. Ricci-Vitiani L, "Identification and expansion of human colon-cancer-initiating cells", Nature, 445, pp.111~115 (2007)
14. Hermann PC, "Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer", Cell Stem Cell, 1, pp.313~323 (2007)
15. Eramo A, "Identification and expansion of the tumorigenic lung cancer stem cell population", Cell Death Differ, 15, pp.504~514 (2008)
16. Collins AT, "Prospective identification of tumorigenic prostate cancer stem cells", Cancer Res, 65, pp.10946~10951 (2005)
17. Yang ZF, "Significance of CD90+ cancer stem cells in human liver cancer", Cancer Cell, 13, pp.153~166 (2008)
18. Schatton T, "Identification of cells initiating human melanomas", Nature, 451, pp.345~349 (2008)
19. Curley MD, "CD133 expression defines a tumor initiating cell population in primary human ovarian cancer", Stem Cells, 27, pp.2875~2883 (2009)
20. Visvader JE, "Cancer stem cells in solid tumours: accumulating evidence and unresolved questions", Nat Rev Cancer, 8, pp.755~768 (2008)
21. Alison MR, "Liver stem cells: implications for hepatocarcinogenesis", Stem Cell Rev, 1, pp.253~260 (2005)
22. Haraguchi N, "Characterization of a side population of cancer cells from human gastrointestinal system", Stem Cells, 24, pp.506~513 (2006)
23. Ma S, "Identification and characterization of tumorigenic liver cancer stem", progenitor cells, 2007, pp.132, 2542~2556
24. Yamashita T, "EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem", progenitor cell features, 2009, pp.136, 1012~1024
25. Zhu Z, "Cancer stem", progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma, 2010, pp.126, 2067~2078
26. Haraguchi N, "CD13 is a therapeutic target in human liver cancer stem cells", J Clin Invest, 120, pp.3326~3339 (2010)
27. O’Brien CA, "Cancer stem cells and selfrenewal", Clin Cancer Res, 16, pp.3113~3120 (2010)
28. Yang ZF, "Identification of local and circulating cancer stem cells in human liver cancer", Hepatology, 47, pp.919~928 (2008)
29. Weigmann A, "Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells", Proc Natl Acad Sci U S A, 94, pp.12425~12430 (1997)
30. Suetsugu A, "Characterization of CD133+ hepatocellular carcinoma cells as cancer stem", progenitor cells, 2006, pp.351, 820~824
31. Aravalli RN, "Molecular mechanisms of hepatocellular carcinoma", Hepatology, 48, pp.2047~2063 (2008)
32. Hur W, "SOX4 overexpression regulates the p53-mediated apoptosis in hepatocellular carcinoma: clinical implication and functional analysis in vitro", Carcinogenesis, 31, pp.1298~1307 (2010)
33. Evarts RP, "A precursorproduct relationship exists between oval cells and hepatocytes in rat liver", Carcinogenesis, 8, pp.1737~1740 (1987)
34. van Eyken P, "Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient", Virchows Arch A Pathol Anat Histopathol, 412, pp.63~72 (1987)
35. Lai YS, "Expression of cytokeratins in normal and diseased livers and in primary liver carcinomas", Arch Pathol Lab Med, 113, pp.134~138 (1989)
36. Roskams T, "Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man", J Hepatol, 29, pp.455~463 (1998)
37. Bralet MP, "Demonstration of direct lineage between hepatocytes and hepatocellular carcinoma in diethylnitrosamine-treated rats", Hepatology, 36, pp.623~630 (2002)
38. Nagaki M, "Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix", Biochem Biophys Res Commun, 210, pp.38~43 (1995)
39. Wu XZ, "Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed?", Med Hypotheses, 66, pp.1115~1120 (2006)
40. Avril A, "Mature hepatocytes are the source of small hepatocyte-like progenitor cells in the retrorsine model of liver injury", J Hepatol, 41, pp.737~743 (2004)
41. Roskams TA, "Progenitor cells in diseased human liver", Semin Liver Dis, 23, pp.385~396 (2003)
42. Sell S, "Cellular origin of cancer: dedifferentiation or stem cell maturation arrest?", Environ Health Perspect, 101(Suppl 5), pp.15~26 (1993)
43. Sell S, "Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma", Am J Pathol, 134, pp.1347~1363 (1989)
44. Sell S, "Cellular origin of hepatocellular carcinomas", Semin Cell Dev Biol, 13, pp.419~424 (2002)
45. Theise ND, "Hepatic ‘stem cell’ malignancies in adults: four cases", Histopathology, 43, pp.263~271 (2003)
46. Lowes KN, "Oval cell numbers in human chronic liver diseases are directly related to disease severity", Am J Pathol, 154, pp.537~541 (1999)
47. Libbrecht L, "The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells", J Hepatol, 33, pp.76~84 (2000)
48. Libbrecht L, "Preneoplastic lesions in human hepatocarcinogenesis", Liver Int, 25, pp.16~27 (2005)
49. Marshall A, "Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection", Gastroenterology, 128, pp.33~42 (2005)
50. Libbrecht L, "Hepatic progenitor cells in human liver diseases", Semin Cell Dev Biol, 13, pp.389~396 (2002)
51. Ruck P, "Hepatic stem-like cells in hepatoblastoma: expression of cytokeratin 7, albumin and oval cell associated antigens detected by OV-1 and OV-6", Histopathology, 31, pp.324~329 (1997)
52. Desmet V, "Ductular reaction in the liver", Pathol Res Pract, 191, pp.513~524 (1995)
53. Haque S, "Identification of bipotential progenitor cells in human liver regeneration", Lab Invest, 75, pp.699~705 (1996)
54. Yamashita T, "Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma", Cancer Res, 67, pp.10831~10839 (2007)
55. Coulouarn C, "Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer", Hepatology, 47, pp.2059~2067 (2008)
56. Tang Y, "Progenitor", stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling, 2008, pp.105, 2445~2450
57. Gao J, "Deregulated expression of Notch receptors in human hepatocellular carcinoma", Dig Liver Dis, 40, pp.114~121 (2008)
58. Ricci-Vitiani L, "Colon cancer stem cells", J Mol Med, 87, pp.1097~1104 (2009)
59. Wulf GG, "A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia", Blood, 98, pp.1166~1173 (2001)
60. Magni M, "Induction of cyclophosphamide-resistance by aldehydedehydrogenase gene transfer", Blood, 87, pp.1097~1103 (1996)
61. Duxbury MS, "A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells", Cancer Res, 64, pp.3987~3993 (2004)
62. Ma S, "CD133+ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt", PKB survival pathway, 2008, pp.27, 1749~1758
63. Bao S, "Glioma stem cells promote radioresistance by preferential activation of the DNA damage response", Nature, 444, pp.756~760 (2006)
64. Phillips TM, "The response of CD24(-", low), J Natl Cancer Inst, pp.2006, 98[DOI]
65. Woodward WA, "WNT", beta-catenin mediates radiation resistance of mouse mammary progenitor cells, 2007, pp.104, 618~623
66. Clement V, "HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity", Curr Biol, 17, pp.165~172 (2007)
67. Lammering G, "Inhibition of the type III epidermal growth factor receptor variant mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity", Clin Cancer Res, 10, pp.6732~6743 (2004)
68. Puc J, "PTEN loss inhibits CHK1 to cause double stranded-DNA breaks in cells", Cell Cycle, 4, pp.927~929 (2005)
69. Zhou J, "Tumor hypoxia and cancer progression", Cancer Lett, 237, pp.10~21 (2006)
70. Williams KJ, "Enhanced response to radiotherapy in tumours deficient in the function of hypoxiainducible factor-1", Radiother Oncol, 75, pp.89~98 (2005)
71. Baumann M, "Exploring the role of cancer stem cells in radioresistance", Nat Rev Cancer, 8, pp.545~554 (2008)
72. Bernier J, "Radiation oncology: a century of achievements", Nat Rev Cancer, 4, pp.737~747 (2004)
73. Lee JS, "A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells", Nat Med, 12, pp.410~416 (2006)
74. Song W, "Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma", Int J Clin Pract, 62, pp.1212~1218 (2008)
75. Durnez A, "The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin", Histopathology, 49, pp.138~151 (2006)
76. Ma S, "In search of liver cancer stem cells", Stem Cell Rev, 4, pp.179~192 (2008)
77. Cairns J, "Somatic stem cells and the kinetics of mutagenesis and carcinogenesis", Proc Natl Acad Sci U S A, 99, pp.10567~10570 (2002)
78. Phatak P, "Telomerase and its potential for therapeutic intervention", Br J Pharmacol, 152, pp.1003~1011 (2007)
79. Lessard J, "Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells", Nature, 423, pp.255~260 (2003)
80. Münz M, "The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation", Oncogene, 23, pp.5748~5758 (2004)
81. Takahashi-Yanaga F, "Targeting Wnt signaling: can we safely eradicate cancer stem cells?", Clin Cancer Res, 16, pp.3153~3162 (2010)
82. Yilmaz OH, "Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells", Nature, 441, pp.475~482 (2006)
83. Ginestier C, "ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome", Cell Stem Cell, 1, pp.555~567 (2007)
84. Dalerba P, "Phenotypic characterization of human colorectal cancer stem cells", Proc Natl Acad Sci U S A, 104, pp.10158~10163 (2007)
85. Prince ME, "Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma", Proc Natl Acad Sci U S A, 104, pp.973~978 (2007)
86. Zhang S, "Identification and characterization of ovarian cancer-initiating cells from primary human tumors", Cancer Res, 68, pp.4311~4320 (2008)

관련 논문AI추천